Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lechnologies Research, operating as Lohman Technologies, is a medical device company specializing in ambulatory cardiac monitoring and atrial fibrillation detection. Based in Sussex, Wisconsin, the company is best known for developing the AfibAlert, an FDA-cleared handheld ECG monitor that allows patients to detect atrial fibrillation in real-time without the need for a smartphone. Their product portfolio also includes the Genesis ECG Memory Loop Recorder and the hōm ecg+, a cellular-enabled device designed to streamline remote patient monitoring. The company focuses on providing accessible, easy-to-use diagnostic tools that help reduce the risk of stroke and heart attack through early detection of irregular heart rhythms. By integrating advanced algorithms with portable hardware, Lechnologies Research supports both individual patients and healthcare providers in managing chronic cardiac conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lechnologies Research.